Heather Burrell Ward Brian S Barnett Joji Suzuki
10.1080/08897077.2019.1573776
Subst Abus
2019;40(2):140-145.
methadone buprenorphine naltrexone opioid withdrawal
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/30888254/
Buprenorphine / therapeutic use Drug Substitution / methods Methadone / therapeutic use Naltrexone / therapeutic use Narcotic Antagonists / therapeutic use Opiate Substitution Treatment / methods Opioid-Related Disorders / drug therapy Substance Withdrawal Syndrome / drug therapy
Buprenorphine / therapeutic use Drug Substitution / methods Methadone / therapeutic use Naltrexone / therapeutic use Narcotic Antagonists / therapeutic use Opiate Substitution Treatment / methods Opioid-Related Disorders / drug therapy Substance Withdrawal Syndrome / drug therapy Case Reports Adult Antidiarrheals / therapeutic use Antiemetics / therapeutic use Antipruritics / therapeutic use Clonidine / therapeutic use Deprescriptions Female Humans Loperamide / therapeutic use Methocarbamol / therapeutic use Muscle Relaxants, Central / therapeutic use Ondansetron / therapeutic use Promethazine / therapeutic use Substance Withdrawal Syndrome / etiology Sympatholytics / therapeutic use Antidiarrheals Antiemetics Antipruritics Muscle Relaxants, Central Narcotic Antagonists Sympatholytics Methocarbamol Buprenorphine Ondansetron Naltrexone Loperamide Promethazine Clonidine Methadone
PMC7641008
30888254
Rapid transition from methadone to buprenorphine using naltrexone-induced withdrawal: A case report
2019